Enhancer RNA SLIT2 was shown to be lowly expressed in breast cancer, and its knockdown suppressed the proliferative and metastatic abilities of breast oncocytes via modulating P38 MAPK/c-Fos signal path [21]. Here, FOS is linked to breast cancer.